Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | FAP | Q12884 | 1/20 | 0.33 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.33 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29942400 | 1.00 | HPGD (0.33) | HPGDALDH1A1DPP4FAPDPP8 | |
| SCHEMBL25328810 | 0.83 | CSNK2A1 (0.35) | HPGDALDH1A1CYP2A6FFAR1FFAR4 | |
| SCHEMBL332562 | 0.81 | CSNK2A1 (0.34) | HPGDALDH1A1CYP2A6FFAR1FFAR4 | |
| SCHEMBL3181394 | 0.81 | MEP1A (0.41) | HPGDALDH1A1CYP2A6FFAR1FFAR4 | |
| SCHEMBL25786501 | 0.81 | USP8 (0.31) | HPGDALDH1A1CYP2A6FFAR1FFAR4 | |
| SCHEMBL25330851 | 0.81 | MAPT (0.33) | HPGDALDH1A1CYP2A6FFAR1FFAR4 | |
| SCHEMBL16112560 | 0.81 | CYP2A6 (0.31) | HPGDALDH1A1CYP2A6FFAR1FFAR4 | |
| SCHEMBL24108090 | 0.81 | MAPT (0.33) | HPGDALDH1A1CYP2A6FFAR1FFAR4 | |
| SCHEMBL29893592 | 0.80 | HPGD (0.40) | HPGDALDH1A1RIPK1FFAR1FFAR4 | |
| SCHEMBL837981 | 0.80 | HPGD (0.40) | HPGDALDH1A1RIPK1FFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116154298-A | Wide-temperature-zone lithium ion battery electrolyte and preparation method and application thereof | 重庆酷利特科技有限公司 | 2023-05-23 | — | — | CN | claimed |
| CN-217614767-U | Trifluoro-benzene acetonitrile acid environment reaction equipment | 福建润华化工有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-116154298-A | Wide-temperature-zone lithium ion battery electrolyte and preparation method and application thereof | 重庆酷利特科技有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-217614767-U | Trifluoro-benzene acetonitrile acid environment reaction equipment | 福建润华化工有限公司 | 2022-10-21 | — | — | CN | disclosed |
| US-8097733-B2 | Pyrazole derivatives as 5-LO-inhibitors | PFIZER INC. (US) | 2012-01-17 | — | — | US | disclosed |
| EP-2225229-A1 | PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS | Pfizer Inc. (US) | 2010-09-08 | — | — | EP | disclosed |
| US-20090227634-A1 | Pyrazole Derivatives as 5-LO-Inhibitors | PFIZER INC. | 2009-09-10 | — | — | US | disclosed |
| WO-2009069044-A1 | PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS | PFIZER INC. (US) | 2009-06-04 | — | — | WO | disclosed |
| US-6528657-B2 | For use in electroluminescence light emission element and can emit lights of various colors when an energy such as electric energy or electromagnetic energy is applied thereto | TAIHO INDUSTRIES CO., LTD. (JP) | 2003-03-04 | — | — | US | disclosed |
| US-20030023099-A1 | Novel fluorescent carbazole derivative | HIROSE ENGINEERING CO., LTD. (JP) | 2003-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227634-A1 | Pyrazole Derivatives as 5-LO-Inhibitors | ALOX5, ALOX15, CYP3A5 | HPGD 58/4885ALDH1A1 224/4885DPP4 1129/4885 |
| US-20030023099-A1 | Novel fluorescent carbazole derivative | CBR3, AANAT, SIRT3 | HPGD 2494/4885ALDH1A1 1143/4885DPP4 1330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.